SCHEMBL4883665

SCHEMBL4883665

Cc1[nH]nc(-c2ccc(O)cc2O)c1Oc1ccc(Cl)cc1Cl

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR2 Q9HBW0 5/20 0.72
MEN1 O00255 9/20 0.61
KMT2A Q03164 9/20 0.61
MAPT P10636 9/20 0.61
ALOX12 P18054 8/20 0.61
LMNA P02545 6/20 0.61
GPR55 Q9Y2T6 4/20 0.61
HTT P42858 3/20 0.61
HIF1A Q16665 1/20 0.61
GAA P10253 2/20 0.60
NPSR1 Q6W5P4 6/20 0.56
ALOX15 P16050 4/20 0.56
MAPK1 P28482 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2C19 P33261 2/20 0.56
AMY1A P0DUB6 1/20 0.56
USP2 O75604 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4881284 0.84 MEN1 (0.79) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4879539 0.78 TTR (0.51) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4879645 0.77 MEN1 (0.70) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4877166 0.77 MEN1 (0.70) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4884164 0.76 MEN1 (1.00) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4879474 0.76 MEN1 (0.77) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4882094 0.74 MEN1 (0.79) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4871745 0.74 MEN1 (0.79) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL4882748 0.72 MEN1 (0.80) LPAR2MEN1KMT2AMAPTALOX12
SCHEMBL22672252 0.72 MAPT (1.00) MEN1KMT2AMAPTALOX12LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P LPAR2 4509/4885MEN1 4568/4885KMT2A 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.